New data collected by the FDA has found that montelukast can bind to brain cells, which may explain the risk of mental health ...

There are currently no FDA- or EMA-approved treatment options available for any form of frontotemporal dementia.

The EC has approved BeiGene’s PD-1 inhibitor Tevimbra in combination with chemotherapy to treat ESCC and G/GEJ adenocarcinoma ...

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

U.S. FDA Approves AOP Health’s Rapiblyk™ (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting ...

Embryo-Fetal Toxicity ZIIHERA can cause fetal harm when administered to a pregnant woman. In literature reports, use of a HER2-directed antibody during p ...

Bolivia’s highest court has approved the extradition to the United States of a former anti-narcotics chief on charges of ...

Verastem's promising progress in RAS-driven cancers, potential FDA approval, and growth opportunities present a bullish ...

Cody Holgate, 30, is taking a new epilepsy drug called Xcopri, despite it not being approved for coverage in Saskatchewan.

Takers of GLP-1 are reportedly going on a "holiday pause" to enjoy meal centric family celebrations. Here, an MD breaks down ...

People whose partners have HIV must remember to take antiretroviral pills every single day or risk infection themsel ...

A recent article authored by Haider J. Warraich, MD; Troy Tazbaz; and Robert M. Califf, MD in the Journal of the American ...